What is Alpha Genesis?
Alpha Genesis operates as a premier provider of primate research services and biological resources, serving a global clientele within the pharmaceutical and academic research communities. The company distinguishes itself through high-standard ethical practices and specialized facilities designed to support complex biomedical studies. By maintaining a critical supply chain for primate models, Alpha Genesis occupies a unique niche in the life sciences ecosystem, facilitating essential drug discovery and health research initiatives that require precise, high-quality biological subjects.
How much funding has Alpha Genesis raised?
Alpha Genesis has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Alpha Genesis
PPP
Public-Private Partnership
What's next for Alpha Genesis?
With the infusion of this recent capital, Alpha Genesis is positioned to accelerate its infrastructure development and expand its research service capabilities. The strategic focus will likely shift toward enhancing facility capacity and integrating advanced monitoring technologies to meet the rising demand for high-fidelity research models. As the company navigates the complexities of late-stage growth, the management team is expected to prioritize operational excellence and regulatory compliance, ensuring that their service offerings remain at the forefront of the global life sciences market. This financing round serves as a catalyst for sustained innovation and market leadership in the years ahead.
See full Alpha Genesis company page
